AN OBSERVATIONAL, PROSPECTIVE, MULTINATIONAL, MULTICENTRE STUDY COMPARING THE EFFECTIVENESS OF SAFINAMIDE, RASAGILINE AND OTHER “STANDARD OF CARE” AS ADD-ON THERAPY TO LEVODOPA (L-DOPA) IN PARKINSON’S DISEASE (PD) FLUCTUATING PATIENTS (SUCCESS) First published 25/05/2021 Last updated 30/10/2023 EU PAS number:EUPAS41248 Study Ongoing